Outlook Therapeutics, Inc. Quarterly Depreciation in USD from Q4 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Outlook Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q4 2019 to Q3 2022.
  • Outlook Therapeutics, Inc. Depreciation for the quarter ending September 30, 2022 was $40.9K, unchanged year-over-year.
  • Outlook Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2022 was $164K, a 0% increase year-over-year.
  • Outlook Therapeutics, Inc. annual Depreciation for 2022 was $164K, a 0% increase from 2021.
  • Outlook Therapeutics, Inc. annual Depreciation for 2021 was $164K, a 25.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $164K $40.9K $0 0% Jul 1, 2022 Sep 30, 2022 10-K 2022-12-29
Q2 2022 $164K $40.9K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $164K $40.9K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $164K $40.9K +$1.00 +0% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $164K $40.9K $0 0% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-29
Q2 2021 $164K $40.9K -$10.1K -19.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $174K $40.9K -$22.9K -35.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $197K $40.9K -$22.9K -35.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $219K $40.9K Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 $51K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $63.8K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $63.8K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.